Veeva Systems Research and Development Expenses 2013-2026 | VEEV
Veeva Systems annual/quarterly research and development expenses history and growth rate from 2013 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Veeva Systems research and development expenses for the quarter ending January 31, 2026 were $0.199B, a 9.51% increase year-over-year.
- Veeva Systems research and development expenses for the twelve months ending January 31, 2026 were $0.767B, a 10.72% increase year-over-year.
- Veeva Systems annual research and development expenses for 2026 were $0.767B, a 10.72% increase from 2025.
- Veeva Systems annual research and development expenses for 2025 were $0.693B, a 10.18% increase from 2024.
- Veeva Systems annual research and development expenses for 2024 were $0.629B, a 20.9% increase from 2023.
|
Veeva Systems Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2026 | $767 |
| 2025 | $693 |
| 2024 | $629 |
| 2023 | $520 |
| 2022 | $382 |
| 2021 | $294 |
| 2020 | $210 |
| 2019 | $159 |
| 2018 | $132 |
| 2017 | $97 |
| 2016 | $66 |
| 2015 | $41 |
| 2014 | $26 |
| 2013 | $15 |
| 2012 | $8 |
|
Veeva Systems Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2026-01-31 | $199 |
| 2025-10-31 | $192 |
| 2025-07-31 | $193 |
| 2025-04-30 | $184 |
| 2025-01-31 | $182 |
| 2024-10-31 | $172 |
| 2024-07-31 | $176 |
| 2024-04-30 | $163 |
| 2024-01-31 | $164 |
| 2023-10-31 | $161 |
| 2023-07-31 | $157 |
| 2023-04-30 | $147 |
| 2023-01-31 | $143 |
| 2022-10-31 | $130 |
| 2022-07-31 | $134 |
| 2022-04-30 | $113 |
| 2022-01-31 | $105 |
| 2021-10-31 | $99 |
| 2021-07-31 | $95 |
| 2021-04-30 | $83 |
| 2021-01-31 | $82 |
| 2020-10-31 | $80 |
| 2020-07-31 | $70 |
| 2020-04-30 | $62 |
| 2020-01-31 | $61 |
| 2019-10-31 | $53 |
| 2019-07-31 | $51 |
| 2019-04-30 | $45 |
| 2019-01-31 | $43 |
| 2018-10-31 | $40 |
| 2018-07-31 | $39 |
| 2018-04-30 | $37 |
| 2018-01-31 | $37 |
| 2017-10-31 | $34 |
| 2017-07-31 | $33 |
| 2017-04-30 | $28 |
| 2017-01-31 | $26 |
| 2016-10-31 | $25 |
| 2016-07-31 | $24 |
| 2016-04-30 | $22 |
| 2016-01-31 | $20 |
| 2015-10-31 | $18 |
| 2015-07-31 | $15 |
| 2015-04-30 | $13 |
| 2015-01-31 | $12 |
| 2014-10-31 | $11 |
| 2014-07-31 | $10 |
| 2014-04-30 | $9 |
| 2014-01-31 | $8 |
| 2013-10-31 | $7 |
| 2013-07-31 | $6 |
| 2013-04-30 | $6 |
| 2013-01-31 | |
| 2012-10-31 | $4 |
| 2012-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $24.733B | $3.195B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |